SCHEMBL6779185

SCHEMBL6779185

COc1ccccc1N1CCN(C(=O)CNC(=O)C(Nc2cccc(C(=N)N)c2)c2ccc(-c3ccccc3)cc2)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.47
POLB P06746 1/20 0.47
KMT2A Q03164 1/20 0.47
DRD2 P14416 6/20 0.43
DRD3 P35462 6/20 0.43
DRD4 P21917 3/20 0.43
FAAH O00519 3/20 0.43
THRB P10828 1/20 0.43
TSHR P16473 1/20 0.43
SLC6A2 P23975 1/20 0.42
SLC6A4 P31645 1/20 0.42
F10 P00742 2/20 0.42
F2 P00734 2/20 0.42
KDM4E B2RXH2 1/20 0.42
KCNH2 Q12809 1/20 0.42
PRSS1 P07477 1/20 0.42
F7 P08709 1/20 0.42
HTR1A P08908 2/20 0.42
MAPT P10636 2/20 0.42
RAB9A P51151 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6780268 0.95 F10 (0.46) MEN1POLBKMT2ADRD2DRD3
SCHEMBL6779801 0.94 F10 (0.43) MEN1POLBKMT2ADRD2DRD3
SCHEMBL6780280 0.91 LMNA (0.47) MEN1POLBKMT2ATSHRF10
SCHEMBL6778302 0.88 POLB (0.45) MEN1POLBKMT2ADRD2DRD4
SCHEMBL6785087 0.88 MAPT (0.46) MEN1POLBKMT2AF10F2
SCHEMBL6779135 0.88 TSHR (0.44) MEN1POLBKMT2ADRD2DRD3
SCHEMBL6777979 0.87 KDM4E (0.44) MEN1POLBKMT2ADRD2DRD3
SCHEMBL6779349 0.87 TSHR (0.48) MEN1POLBKMT2ADRD2DRD3
Hydrochloric Acid SCHEMBL6366397 0.86 TSHR (0.48) MEN1KMT2ADRD2DRD3DRD4
SCHEMBL6774764 0.86 F2 (0.55) MEN1POLBKMT2ATSHRF10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6794507-B2 Compounds that inhibit factor Xa activity MORPHOCHEM AG (DE) 2004-09-21 US disclosed
US-20030153510-A1 Novel compounds inhibiting factor xa activity CAPPI MICHAEL W (DE) 2003-08-14 US disclosed
EP-1311473-A2 NOVEL COMPOUNDS INHIBITING FACTOR XA ACTIVITY Morphochem AG (DE) 2003-05-21 EP disclosed
WO-2002016312-A2 NOVEL COMPOUNDS INHIBITING FACTOR XA ACTIVITY MORPHOCHEM AG (DE) 2002-02-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030153510-A1 Novel compounds inhibiting factor xa activity SERPINC1, F11, TFPI MEN1 592/4885POLB 4322/4885KMT2A 4159/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.